CN111172222A - Method for producing hyaluronic acid by fermentation and application thereof - Google Patents
Method for producing hyaluronic acid by fermentation and application thereof Download PDFInfo
- Publication number
- CN111172222A CN111172222A CN201911379590.2A CN201911379590A CN111172222A CN 111172222 A CN111172222 A CN 111172222A CN 201911379590 A CN201911379590 A CN 201911379590A CN 111172222 A CN111172222 A CN 111172222A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- hyaluronic acid
- culture medium
- hours
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 136
- 230000004151 fermentation Effects 0.000 title claims abstract description 136
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 106
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 105
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 105
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 40
- 239000008103 glucose Substances 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 34
- 241000120569 Streptococcus equi subsp. zooepidemicus Species 0.000 claims abstract description 31
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 25
- 230000001502 supplementing effect Effects 0.000 claims abstract description 11
- 230000003213 activating effect Effects 0.000 claims abstract description 3
- 239000001963 growth medium Substances 0.000 claims description 40
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 34
- 239000002609 medium Substances 0.000 claims description 32
- 238000011218 seed culture Methods 0.000 claims description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 238000012258 culturing Methods 0.000 claims description 19
- 239000001888 Peptone Substances 0.000 claims description 17
- 108010080698 Peptones Proteins 0.000 claims description 17
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 17
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 17
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 17
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 17
- 235000019319 peptone Nutrition 0.000 claims description 17
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 12
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 12
- 229940073490 sodium glutamate Drugs 0.000 claims description 12
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 238000012869 ethanol precipitation Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000009423 ventilation Methods 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 238000005273 aeration Methods 0.000 claims description 3
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims 1
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 claims 1
- 229940014041 hyaluronate Drugs 0.000 claims 1
- 230000012010 growth Effects 0.000 abstract description 6
- 230000001580 bacterial effect Effects 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 241001052560 Thallis Species 0.000 abstract description 3
- 238000011109 contamination Methods 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 238000004659 sterilization and disinfection Methods 0.000 description 16
- 229920002385 Sodium hyaluronate Polymers 0.000 description 9
- 229940010747 sodium hyaluronate Drugs 0.000 description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 7
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229960003589 arginine hydrochloride Drugs 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000003796 beauty Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides a method for producing hyaluronic acid by fermentation and application thereof. The method comprises the following steps: and (3) activating and expanding streptococcus zooepidemicus, fermenting, supplementing a primary carbon source in the fermentation process to obtain hyaluronic acid fermentation liquor, and purifying to obtain hyaluronic acid. According to the fermentation method provided by the invention, the primary carbon source is added in the fermentation process, so that the concentration of glucose in the fermentation liquor can be maintained, the fermentation period is shortened, the bacterial contamination risk caused by adding the carbon source for multiple times is avoided, the normal growth and metabolism of thalli are facilitated, the problem of imbalance between the self metabolism and the product expression of streptococcus zooepidemicus is solved, and the obtained hyaluronic acid has high yield and relatively large molecular weight.
Description
Technical Field
The invention belongs to the technical field of fermentation, and particularly relates to a method for producing hyaluronic acid by fermentation, in particular to a method for producing high-molecular pharmaceutical-grade hyaluronic acid by fermentation and application thereof.
Background
Hyaluronic Acid (HA) is also called hyaluronic acid, and is a macromolecular mucopolysaccharide, which is a chain-shaped high molecular polymer formed by repeatedly and alternately connecting glucuronic acid and N-acetylglucosamine through β -1,3 and β -1,4 glycosidic bonds, based on the high viscosity, lubricity, water retention, good biocompatibility and special physiological action of hyaluronic acid, the hyaluronic acid HAs wide application in the fields of medicine, beauty treatment, health food and the like, HA with different purposes HAs different requirements on molecular weight, HA with medium molecular weight (molecular weight range of 1,000-1,800KDa) is mainly used in cosmetics, while HA with high molecular weight (molecular weight range of 1,800-2,200KDa) can be used in ophthalmological adhesive surgery, joint disease treatment, soft tissue repair, drug carriers and the like, and particularly HAs high application value in preventing and reducing postoperative tissue adhesion.
The hyaluronic acid production method comprises animal organ extraction method and bacterial fermentation method. When the extraction method is adopted to extract HA from animal viscera, the raw materials are limited, the production cost is high, the commodity price is high, and the wide application of HA in medicines and cosmetics is limited. Compared with an animal tissue extraction method, the bacterial fermentation method HAs the advantages that the production scale is not limited by animal raw materials, HA in fermentation liquor exists in a free form, the separation and purification are easy, the cost is low, large-scale industrial production is easy to form, the risk of animal-derived pathogenic virus pollution is avoided, and the like.
CN101935678A discloses a method for producing a hyaluronic acid fermentation broth, wherein a trace element liquid is added in a culture medium, the trace element liquid is composed of calcium chloride, zinc chloride, manganese sulfate and copper sulfate, and water for injection is used for preparing a seed culture medium and a fermentation culture medium, so that the problem of hyaluronic acid yield and quality reduction caused by nutrient substance deficiency or improper blending of various nutrient substances in the process of producing hyaluronic acid by bacterial fermentation is solved, however, the yield of hyaluronic acid in the invention is 6-7g/L, and the yield is still low.
CN109536550A discloses a preparation method of sodium hyaluronate, which improves the yield of sodium hyaluronate, realizes the control of the molecular weight of sodium hyaluronate and expands the application field of sodium hyaluronate by reasonably planning a fermentation process and optimally preparing a fermentation culture medium. According to the method, a carbon source is supplemented by adopting a fed-batch method during fermentation, and the carbon source is supplemented for five times at different times respectively, so that the yield of the obtained hyaluronic acid is high.
Therefore, it is required to provide a fermentation method for preparing hyaluronic acid with high yield and high molecular weight of hyaluronic acid to meet the market demand.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a method for producing hyaluronic acid by fermentation and application thereof. The method is simple to operate, can shorten the fermentation period and increase the yield of the hyaluronic acid, and the obtained hyaluronic acid has higher molecular weight. In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the present invention provides a method for the fermentative production of hyaluronic acid, comprising the steps of: and (3) activating and expanding streptococcus zooepidemicus, fermenting, supplementing a primary carbon source in the fermentation process to obtain hyaluronic acid fermentation liquor, and purifying to obtain hyaluronic acid.
In the fermentation process, the initial glucose concentration is too high, so that the growth inhibition is caused to the growth of strains, the fermentation period is prolonged, and the yield of the hyaluronic acid is influenced by the too low glucose concentration.
Preferably, the content of hyaluronic acid in the hyaluronic acid fermentation liquor is 10-15.5g/L, and can be, for example, 10g/L, 10.2g/L, 10.5g/L, 11g/L, 11.5g/L, 12g/L, 13g/L, 14g/L, 14.5g/L, 15g/L or 15.5g/L, etc.
Preferably, the molecular weight of the hyaluronic acid is 2200 to 4500KDa, such as 2200KDa, 2500KDa, 2800KDa, 3000KDa, 3500KDa, 4000KDa or 4500KDa, etc.
The hyaluronic acid obtained by the invention has high yield which can basically reach 10-15.5g/L, and the product has high molecular weight, can be used as a pharmaceutical grade high molecular weight raw material, can be further developed into orthopedic injection, eye drops, ophthalmic surgery viscoelastic agent, injection beauty filling product and surgery anti-adhesion product, and has wide application range and high additional value.
As a preferred technical scheme of the invention, the carbon source is glucose.
Preferably, the carbon source is supplemented in an amount of 10-20g/L fermentation broth, such as 10g, 11g, 12g, 13g, 14g, 15g, 16g, 17g, 18g, 19g, 20g, etc.
Preferably, the carbon source is supplemented for 4 to 18 hours after the transfer of the strain to the fermentation medium after the amplification, for example, 4 hours, 5 hours, 6 hours, 8 hours, 10 hours, 12 hours, 14 hours, 16 hours or 18 hours, preferably 16 hours.
Preferably, the fermentation medium used in the fermentation comprises 50-100g/L (e.g., 50g/L, 55g/L, 60g/L, 65g/L, 70g/L, 75g/L, 80g/L, 85g/L, 90g/L, 95g/L, or 100g/L, etc.) glucose, 5-10g/L (e.g., 5g/L, 5.5g/L, 6g/L, 6.5g/L, 7g/L, 7.5g/L, 8g/L, 8.5g/L, 9g/L, 9.5g/L, or 10g/L, etc.) yeast powder, 10-20g/L (e.g., 10g/L, 12g/L, 14g/L, 15g/L, C, 16g/L, 18g/L, 19g/L, 20g/L, etc.), peptone, magnesium sulfate, potassium dihydrogen phosphate, sodium glutamate, and sodium glutamate, wherein the peptone is 0.5-2g/L (for example, 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, 2g/L, etc.), magnesium sulfate, 0.5-2g/L (for example, 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, 2g/L, etc.), potassium dihydrogen phosphate, 10-20g/L (for example, 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, 19g/L, 20g/L, etc.), sodium glutamate, and 1-5g/L (for example, 1g/L, 1, 2g/L, 1.5g/L, 2g/L, 2.5g/L, 3g/L, 3.5g/L, 4g/L, 4.5g/L, or 5g/L, etc.) arginine hydrochloride.
Preferably, the transfer amount of the strain to the fermentation medium after the propagation is 3 to 5%, for example, 3%, 3.2%, 3.5%, 3.8%, 4%, 4.2%, 4.5%, 4.8%, or 5%.
Preferably, the stirring speed during the fermentation is 100 to 500rpm, and may be, for example, 100rpm, 150rpm, 200rpm, 250rpm, 300rpm, 350rpm, 400rpm, 450rpm or 500rpm, etc.
Preferably, the fermentation temperature is 33-37 ℃, for example, 33 ℃, 33.5 ℃, 34 ℃, 34.5 ℃, 35 ℃, 35.5 ℃, 36 ℃, 36.5 ℃ or 37 ℃.
Preferably, the fermentation time is 20-24h, for example 20h, 20.5h, 21h, 21.5h, 22h, 22.5h, 23h, 23.5h or 24h, etc.
Preferably, the aeration rate during the fermentation is 1 to 3vvm, and may be, for example, 1vvm, 1.2vvm, 1.5vvm, 2vvm, 2.2vvm, 2.5vvm, 2.6vvm, 2.8vvm, 3vvm, or the like.
As a preferable technical scheme of the invention, the fermentation process also comprises a step of adjusting the pH of the fermentation liquor by using a pH regulator.
Preferably, the pH adjusting agent is sodium hydroxide.
Preferably, the pH of the fermentation broth is maintained between 7.0 and 8.0, and may be, for example, 7.0, 7.2, 7.4, 7.6, 7.8, 7.9, 8.0, or the like.
In a preferred embodiment of the present invention, the temperature at the time of activation in the above-mentioned method is 33 to 37 ℃ and may be, for example, 33 ℃, 33.5 ℃, 34 ℃, 34.5 ℃, 35 ℃, 35.5 ℃, 36 ℃, 36.5 ℃ or 37 ℃; the time is 10 to 14 hours, for example, 10 hours, 10.5 hours, 11 hours, 11.5 hours, 12 hours, 12.5 hours, 13 hours or 13.5 hours.
Preferably, the medium used in the activation is a shake flask seed medium.
Preferably, the shake flask seed medium comprises 1-10g/L (e.g., can be 1g/L, 2g/L, 4g/L, 5g/L, 6g/L, 8g/L, 9g/L, or 10g/L, etc.) glucose, 5-10g/L (e.g., can be 5g/L, 5.5g/L, 6g/L, 6.5g/L, 7g/L, 7.5g/L, 8g/L, 8.5g/L, 9g/L, 9.5g/L, or 10g/L, etc.) yeast powder, 10-20g/L (e.g., can be 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, 19g/L, or 20g/L, etc.) peptone, 0.5-2g/L (for example, 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, 2g/L, etc.) magnesium sulfate and 0.5-2g/L (for example, 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, 2g/L, etc.) potassium dihydrogen phosphate.
In a preferred embodiment of the present invention, the temperature during the amplification in the method is 33 to 37 ℃ and may be, for example, 33 ℃, 33.5 ℃, 34 ℃, 34.5 ℃, 35 ℃, 35.5 ℃, 36 ℃, 36.5 ℃ or 37 ℃; the time is 8 to 12 hours, and may be, for example, 8 hours, 8.5 hours, 9 hours, 9.5 hours, 10 hours, 10.5 hours, 11 hours, 11.5 hours, 12 hours, or the like.
Between the seed culture and fermentation culture stages of streptococcus zooepidemicus, a seed tank expanding culture step is added, so that the strain is quickly adapted to the nutrient environment provided by a fermentation culture medium, and enters the fermentation stage, the nutrition in the fermentation culture can be quickly utilized for growth, and the fermentation period is shortened.
Preferably, the culture medium used in the expanding culture is a seed tank seed culture medium.
Preferably, the seedpot seed medium comprises 1-10g/L (e.g., can be 1g/L, 2g/L, 4g/L, 5g/L, 6g/L, 8g/L, 9g/L, or 10g/L, etc.) glucose, 5-10g/L (e.g., can be 5g/L, 5.5g/L, 6g/L, 6.5g/L, 7g/L, 7.5g/L, 8g/L, 8.5g/L, 9g/L, 9.5g/L, or 10g/L, etc.) yeast powder, 10-20g/L (e.g., can be 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, 19g/L, or 20g/L, etc.) peptone, 0.5-2g/L (e.g., 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, 2g/L, etc.) magnesium sulfate, 0.5-2g/L (e.g., 0.5g/L, 0.8g/L, 1g/L, 1.2g/L, 1.5g/L, 1.8g/L, 2g/L, etc.) potassium dihydrogen phosphate, and 10-20g/L (e.g., 10g/L, 12g/L, 14g/L, 15g/L, 16g/L, 18g/L, 19g/L, 20g/L, etc.) sodium glutamate.
Preferably, the method used for purifying the hyaluronic acid fermentation broth is ethanol precipitation.
The ethanol precipitation method is a commonly used method for separating various polysaccharides, can effectively dehydrate and decolor hyaluronic acid so as to improve the product quality of the hyaluronic acid, and in order to ensure that the hyaluronic acid is completely precipitated, about 1 percent of NaCl or NaAc is added to achieve proper ionic concentration due to the fact that the solution has enough ionic strength, and the adding amount of ethanol is generally 2 times of the volume of fermentation liquor.
As a preferred technical scheme of the invention, the method comprises the following steps:
(1) inoculating Streptococcus zooepidemicus into shake flask seed culture medium, culturing at 33-37 deg.C for 10-14 hr, transferring to seed tank seed culture medium, and culturing at 33-37 deg.C for 8-12 hr;
(2) transferring streptococcus zooepidemicus in seed tank seed culture medium into fermentation culture medium at 3-5%, fermenting at 33-37 deg.C under stirring at 100-500rpm, and maintaining pH of the fermentation liquid at 7.0-8.0 and ventilation amount of 1-3 vvm;
(3) and (3) transferring the strain to a fermentation culture medium, adding a primary carbon source for 4-16 hours, wherein the fermentation time is 20-24 hours, obtaining hyaluronic acid fermentation liquor after the fermentation is finished, and purifying by using an ethanol precipitation method to obtain hyaluronic acid.
In a second aspect, the present invention provides the use of a method as described in the first aspect for the preparation of pharmaceutical grade hyaluronic acid and/or a hyaluronic acid salt.
The recitation of numerical ranges herein includes not only the above-recited numerical values, but also any numerical values between non-recited numerical ranges, and is not intended to be exhaustive or to limit the invention to the precise numerical values encompassed within the range for brevity and clarity.
Compared with the prior art, the invention has the beneficial effects that:
(1) the method for producing hyaluronic acid by fermentation provided by the invention can maintain the concentration of glucose in the fermentation liquor, is beneficial to normal growth and metabolism of thalli, shortens the fermentation period, avoids the risk of contamination caused by supplementing a carbon source for many times, and solves the problem that the yield and the molecular weight of hyaluronic acid are small due to imbalance between the self-metabolism and product expression of streptococcus zooepidemicus;
(2) the hyaluronic acid prepared by the method has high yield, the content of hyaluronic acid in hyaluronic acid fermentation liquor can reach 15.5g/L, the molecular weight is high, the application value of hyaluronic acid with high molecular weight is high, and meanwhile, the method is simple to operate, short in fermentation period, high in production efficiency and beneficial to industrial production.
Detailed Description
The technical solution of the present invention is further explained by the following embodiments. It should be understood by those skilled in the art that the examples are only for the understanding of the present invention and should not be construed as the specific limitations of the present invention.
In the following examples, the formulation of the seed solid medium used was: 10g/L of glucose, 5g/L of yeast powder, 10g/L of peptone, 1g/L of magnesium sulfate, 1g/L of monopotassium phosphate and 20g of agar; the sterilization temperature after the culture medium is configured is 115 ℃, and the sterilization time is 20 minutes.
In the following examples, the formulation of the shake flask seed medium used was: 10g/L of glucose, 5g/L of yeast powder, 10g/L of peptone, 1g/L of magnesium sulfate and 1g/L of monopotassium phosphate; the sterilization temperature after the culture medium is configured is 115 ℃, and the sterilization time is 20 minutes.
In the following examples, the formulation of the seed tank seed medium used was: 10g/L of glucose, 5g/L of yeast powder, 10g/L of peptone, 1g/L of magnesium sulfate, 1g/L of monopotassium phosphate and 20g/L of sodium glutamate; the sterilization temperature after the culture medium is configured is 115 ℃, and the sterilization time is 20 minutes.
In the following examples, the fermentation medium used was formulated as follows: the concentration of glucose is 90g/L, the concentration of yeast powder is 10g/L, the concentration of peptone is 20g/L, the concentration of magnesium sulfate is 0.5g/L, the concentration of potassium dihydrogen phosphate is 2g/L, the concentration of sodium glutamate is 20g/L, and the concentration of arginine hydrochloride is 5 g/L; the sterilization temperature is 121 ℃ after the culture medium is prepared, and the sterilization time is 30 min.
Example 1
The embodiment provides a method for producing hyaluronic acid by fermentation, which comprises the following steps:
1. inoculating streptococcus zooepidemicus to a seed solid culture medium by taking streptococcus zooepidemicus as a fermentation strain, culturing at 33 ℃ for 16 h;
2. inoculating streptococcus zooepidemicus to a shake flask seed culture medium for culture, and carrying out shake culture at 33 ℃ for 12h to obtain a streptococcus zooepidemicus shake flask seed culture solution;
3. inoculating the streptococcus zooepidemicus shake-flask seed culture solution to a seed tank culture medium for culture, adjusting the pH of the culture solution with 30% sodium hydroxide at the culture temperature of 33 ℃, maintaining the pH at 7.5, and culturing for 12h to obtain a streptococcus zooepidemicus seed tank seed culture solution;
4. inoculating seed culture solution of streptococcus zooepidemicus seed tank into a 50L fermentation tank, wherein the fermentation tank contains 30L fermentation medium, the inoculation amount is 5%, and the stirring speed is 250rpm after inoculation; culturing for 4 hours at the temperature of 33 ℃, the pH value of 7.5 and the ventilation volume of 1vvm, supplementing 10g of glucose into each liter of fermentation broth, continuously culturing, adjusting the pH value of the fermentation broth by using 30% sodium hydroxide in the fermentation process to keep the pH value at 7.5 +/-0.5, and fermenting for 24 hours to obtain 30L of hyaluronic acid fermentation broth;
5. and adding 58L of ethanol into 200g of NaCl in the obtained fermentation liquor to precipitate sodium hyaluronate to obtain sodium hyaluronate, converting the amount of hyaluronic acid according to the yield of sodium hyaluronate, measuring the intrinsic viscosity by using a Hill's viscometer, and converting the relative molecular weight, wherein the yield of hyaluronic acid is 10.2g/L, and the molecular weight of hyaluronic acid is 2200 KDa.
Example 2
The same as in example 1, except that 10g of glucose per liter of fermentation broth was fed in at 8 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid was 10.6g/L, and the molecular weight of the hyaluronic acid was 2400 kDa.
Example 3
The same as in example 1, except that 10g of glucose per liter of fermentation broth was fed 12 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 10.7g/L, and the molecular weight of the hyaluronic acid is 3000 KDa.
Example 4
The same as in example 1, except that 10g of glucose per liter of fermentation broth was fed in at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 12.4g/L, and the molecular weight of the hyaluronic acid is 3600 KDa.
Example 5
The same as in example 1, except that 10g of glucose per liter of fermentation broth was fed 18 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 11.2g/L, and the molecular weight of the hyaluronic acid is 3400 KDa.
Example 6
The same as in example 1, except that a 500L fermenter was used in this example, the volume of the fermentation medium was 300L, and 10g of glucose was supplied per liter of the fermentation broth at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 12.8g/L, and the molecular weight of the hyaluronic acid is 3800 KDa.
Example 7
The same as in example 1, except that at 16 hours after transfer to the fermentation medium, 5g of glucose was fed per liter of fermentation broth; the yield of the obtained hyaluronic acid is 9.3g/L, and the molecular weight of the hyaluronic acid is 3200 KDa.
Example 8
The same as in example 1, except that 8g of glucose per liter of fermentation broth was fed in at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 10.6g/L, and the molecular weight of the hyaluronic acid is 3400 KDa.
Example 9
The same as in example 1, except that 15g of glucose per liter of fermentation broth was fed in at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 14.2g/L, and the molecular weight of the hyaluronic acid is 4000 KDa.
Example 10
The same as in example 1, except that 20g of glucose per liter of fermentation broth was fed in at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 15.5g/L, and the molecular weight of the hyaluronic acid is 4200 KDa.
Example 11
The same as in example 1, except that 25g of glucose per liter of fermentation broth was fed in at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 15.0g/L, and the molecular weight of the hyaluronic acid is 4200 KDa.
Example 12
The same as in example 1, except that a 500L fermenter was used in this example, the volume of the fermentation medium was 300L, and 15g of glucose was supplied per liter of the fermentation broth at 16 hours after transfer to the fermentation medium; the yield of the obtained hyaluronic acid is 14.4g/L, and the molecular weight of the hyaluronic acid is 4500 KDa.
Comparative example 1
A method for producing a hyaluronic acid fermentation liquid by using streptococcus zooepidemicus as a fermentation strain comprises the following steps:
1. inoculating streptococcus zooepidemicus to seed solid culture for culturing, and culturing at 33 ℃ for 16 hours;
2. preparing a shake flask seed culture medium: 10g/L of glucose, 5g/L of yeast powder, 10g/L of peptone, 1g/L of magnesium sulfate and 1g/L of monopotassium phosphate; the sterilization temperature after the culture medium is configured is 115 ℃, and the sterilization time is 20 minutes.
Inoculating streptococcus zooepidemicus to a seed culture medium for culture, and performing shaking culture at 33 ℃ for 12 hours to obtain a streptococcus zooepidemicus seed culture solution.
3. Preparing a seed culture medium of a seeding tank: 10g/L of glucose, 5g/L of yeast powder, 10g/L of peptone, 1g/L of magnesium sulfate, 1g/L of monopotassium phosphate, 20g/L of sodium glutamate, 115 ℃ of sterilization temperature and 20 minutes of sterilization time.
Inoculating Streptococcus zooepidemicus into seed tank culture medium, culturing at 33 deg.C, adjusting pH to 6.0-8.0 with 30% sodium hydroxide, and culturing for 8-12 hr to obtain Streptococcus zooepidemicus seed culture solution.
4. Preparation of fermenter Medium
The concentration of glucose is 100g/L, the concentration of yeast powder is 10g/L, the concentration of peptone is 20g/L, the concentration of magnesium sulfate is 0.5g/L, the concentration of potassium dihydrogen phosphate is 2g/L, and the concentration of sodium glutamate is 20 g/L; arginine hydrochloride 5g/L, sterilizing at 121 deg.C for 30 min.
Inoculating a streptococcus zooepidemicus seed culture solution to a fermentation culture solution, adjusting the pH value of the fermentation solution by using 30% sodium hydroxide in the fermentation process under the conditions of stirring rotation speed of 200rpm, temperature of 33 ℃, pH value of 7.5 and ventilation volume of 1vvm to keep the pH value at 7.5 +/-0.5, and culturing for 24 hours to obtain hyaluronic acid fermentation solution;
5. 200g NaCl is added into the obtained fermentation liquor, 58L ethanol is added to precipitate sodium hyaluronate, the yield of the obtained hyaluronic acid is 8.1g/L after conversion, and the molecular weight of the hyaluronic acid is 1800 KDa.
Comparative example 2
1. Inoculating streptococcus zooepidemicus to seed solid culture for culturing, and culturing at 33 ℃ for 16 hours;
2. preparing a shake flask seed culture medium: 10g/L of glucose, 5g/L of yeast powder, 10g/L of peptone, 1g/L of magnesium sulfate and 1g/L of monopotassium phosphate; the sterilization temperature after the culture medium is configured is 115 ℃, and the sterilization time is 20 minutes.
Inoculating streptococcus zooepidemicus to a seed culture medium for culture, and performing shaking culture at 33 ℃ for 12 hours to obtain a streptococcus zooepidemicus seed culture solution.
3. Preparing a seed culture medium of a seeding tank: 10g/L of glucose, 5g/L of yeast powder, 10g/L of peptone, 1g/L of magnesium sulfate, 1g/L of monopotassium phosphate, 20g/L of sodium glutamate, 115 ℃ of sterilization temperature and 20 minutes of sterilization time.
Inoculating Streptococcus zooepidemicus into seed tank culture medium, culturing at 33 deg.C, adjusting pH to 8.0 with 30% sodium hydroxide, and culturing for 8-12 hr to obtain Streptococcus zooepidemicus seed culture solution.
4. Preparation of fermenter Medium
The concentration of glucose is 90g/L, the concentration of yeast powder is 10g/L, the concentration of peptone is 20g/L, the concentration of magnesium sulfate is 0.5g/L, the concentration of potassium dihydrogen phosphate is 2g/L, and the concentration of sodium glutamate is 20 g/L; arginine hydrochloride 5g/L, sterilizing at 121 deg.C for 30 min.
Inoculating a streptococcus zooepidemicus seed culture solution to a fermentation culture solution, culturing for 4 hours under the conditions of stirring rotation speed of 200rpm, temperature of 33 ℃, pH value of 7.5 and ventilation volume of 1vvm, supplementing 2g of glucose into each liter of fermentation liquor in the 8 th hour, supplementing 2g of glucose into each liter of fermentation liquor in the 16 th hour, and supplementing 6g of glucose into each liter of fermentation liquor in the 8 th hour; adjusting the pH value of the fermentation liquor by using 30% sodium hydroxide in the fermentation process to keep the pH value at 7.5 +/-0.5, and culturing for 24 hours to obtain hyaluronic acid fermentation liquor;
5. 286g NaCl was added to the obtained fermentation liquid, and 72L ethanol was added to precipitate sodium hyaluronate, and the obtained hyaluronic acid yield was 12.1g/L, and the molecular weight of hyaluronic acid was 3500 KDa.
The glucose addition time, the amount added, and the hyaluronic acid production and hyaluronic acid molecular weight obtained in examples 1 to 12 and comparative examples 1 to 2 above are shown in table 1.
TABLE 1
According to the data in Table 1, as can be seen from the comparison between example 4 and comparative examples 1-2, compared with comparative example 1 in which the carbon source content in the fermentation medium is directly increased without supplementing a carbon source, and comparative example 2 in which an equal amount of carbon source is supplemented for a plurality of times, the hyaluronic acid obtained in example 4 has a higher yield and a larger molecular weight; as can be seen from the comparison between examples 4 and 6 and between examples 9 and 12, the stirring forms of the 500L tank and the 50L tank are different, the 500L tank is stirred more sufficiently, the aeration and dissolved oxygen states are better, the growth of the bacterial cells is facilitated, and the yield and the molecular weight of hyaluronic acid can be improved; however, when the addition amount of glucose is further increased in the amplification experiment, the hyaluronic acid yield and the molecular weight obtained by the 500L tank and the 50L tank are more and more similar; as is clear from comparison of example 4 with example 5, the optimum time point for carbon source addition was found to be 16 hours and 18 hours, respectively, in which the yield decreased and the molecular weight no longer increased; as is clear from comparison of example 4 with examples 7 to 11, the production of hyaluronic acid increases with the amount of carbon source supplementation, and the higher the amount of carbon source supplementation, the higher the production of hyaluronic acid and the larger the molecular weight, but when the amount of carbon source supplementation exceeds 20g/L, for example, when the amount added is 25g/L in example 11, the production of hyaluronic acid does not increase any more, indicating that the production of hyaluronic acid is limited when the concentration of carbon source exceeds a certain range.
In conclusion, the fermentation method provided by the invention can maintain the glucose concentration in the fermentation liquid, shorten the fermentation period, avoid the risk of contamination caused by supplementing carbon sources for many times, is beneficial to normal growth and metabolism of thalli, solves the problem of imbalance between the metabolism of streptococcus zooepidemicus and product expression, and has high yield of the obtained hyaluronic acid and larger molecular weight.
The applicant declares that the above description is only a specific embodiment of the present invention, but the scope of the present invention is not limited thereto, and it should be understood by those skilled in the art that any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope of the present invention are within the scope and disclosure of the present invention.
Claims (10)
1. A method for producing hyaluronic acid by fermentation, which is characterized by comprising the following steps:
and (3) activating and expanding streptococcus zooepidemicus, fermenting, supplementing a primary carbon source in the fermentation process to obtain hyaluronic acid fermentation liquor, and purifying to obtain hyaluronic acid.
2. The method according to claim 1, wherein the content of hyaluronic acid in the hyaluronic acid fermentation broth is 10-15.5 g/L;
preferably, the molecular weight of the hyaluronic acid is 2200 to 4500 KDa.
3. The method of claims 1-2, wherein the carbon source is glucose;
preferably, the mass of the carbon source supplemented in each liter of fermentation liquor is 10-20 g;
preferably, the time for supplementing the carbon source is 4 to 18 hours, preferably 16 hours after the strain is transferred to the fermentation medium after the amplification culture;
preferably, the fermentation medium used in the fermentation comprises 50-100g/L glucose, 5-10g/L yeast powder, 10-20g/L peptone, 0.5-2g/L magnesium sulfate, 0.5-2g/L potassium dihydrogen phosphate, 10-20g/L sodium glutamate and 1-5g/L arginine hydrochloride.
4. The method according to any one of claims 1 to 3, wherein the transfer amount of the strain to the fermentation medium after the propagation is 3 to 5%;
preferably, the stirring speed during fermentation is 100-500 rpm;
preferably, the fermentation temperature is 33-37 ℃;
preferably, the fermentation time is 20-24 h;
preferably, the aeration during the fermentation is 1-3 vvm.
5. The method according to any one of claims 1 to 4, wherein the fermentation process further comprises the step of adjusting the pH of the fermentation broth using a pH adjusting agent;
preferably, the pH adjuster is sodium hydroxide;
preferably, the pH of the fermentation broth is maintained between 7.0 and 8.0.
6. The method according to any one of claims 1 to 5, wherein the temperature at the activation in the method is 33 to 37 ℃ and the time is 10 to 14 hours;
preferably, the culture medium used in the activation is a shake flask seed culture medium;
preferably, the shake flask seed culture medium comprises 1-10g/L glucose, 5-10g/L yeast powder, 10-20g/L peptone, 0.5-2g/L magnesium sulfate and 0.5-2g/L potassium dihydrogen phosphate.
7. The method according to any one of claims 1 to 6, wherein the temperature during propagation is 33 to 37 ℃ and the time is 8 to 12 hours;
preferably, the culture medium used in the expanding culture is a seed tank seed culture medium;
preferably, the seed tank seed culture medium comprises 1-10g/L glucose, 5-10g/L yeast powder, 10-20g/L peptone, 0.5-2g/L magnesium sulfate, 0.5-2g/L potassium dihydrogen phosphate and 10-20g/L sodium glutamate.
8. The method according to any one of claims 1 to 7, wherein the method used for purifying the hyaluronic acid fermentation broth is ethanol precipitation.
9. Method according to any of claims 1-8, characterized in that the method comprises the steps of:
(1) inoculating Streptococcus zooepidemicus into shake flask seed culture medium, culturing at 33-37 deg.C for 10-14 hr, transferring to seed tank seed culture medium, and culturing at 33-37 deg.C for 8-12 hr;
(2) transferring streptococcus zooepidemicus in seed tank seed culture medium into fermentation culture medium at 3-5%, fermenting at 33-37 deg.C under stirring at 100-500rpm, and maintaining pH of the fermentation liquid at 7.0-8.0 and ventilation amount of 1-3 vvm;
(3) and (3) transferring the strain to a fermentation culture medium, adding a primary carbon source for 4-18 hours, wherein the fermentation time is 20-24 hours, obtaining hyaluronic acid fermentation liquor after the fermentation is finished, and purifying by using an ethanol precipitation method to obtain hyaluronic acid.
10. Use of a method according to any one of claims 1 to 9 for the preparation of pharmaceutical grade hyaluronic acid and/or hyaluronate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911379590.2A CN111172222B (en) | 2019-12-27 | 2019-12-27 | Method for producing hyaluronic acid by fermentation and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911379590.2A CN111172222B (en) | 2019-12-27 | 2019-12-27 | Method for producing hyaluronic acid by fermentation and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111172222A true CN111172222A (en) | 2020-05-19 |
CN111172222B CN111172222B (en) | 2024-03-26 |
Family
ID=70624672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911379590.2A Active CN111172222B (en) | 2019-12-27 | 2019-12-27 | Method for producing hyaluronic acid by fermentation and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111172222B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110452944A (en) * | 2019-09-21 | 2019-11-15 | 冯世红 | A method of hyaluronic acid is prepared using salt alcohol method |
CN114806938A (en) * | 2022-04-20 | 2022-07-29 | 齐鲁工业大学 | Streptococcus equi subsp zooepidemicus for producing hyaluronic acid in low-sugar environment and application thereof |
CN115960979A (en) * | 2022-12-30 | 2023-04-14 | 华熙生物科技股份有限公司 | Method for producing hyaluronic acid or salt thereof by fermentation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103320484A (en) * | 2013-06-28 | 2013-09-25 | 四川柯森油田化学有限公司 | Method for improving the fermentation yield of hyaluronic acid (HA) |
CN108192936A (en) * | 2018-03-19 | 2018-06-22 | 山东焦点生物科技股份有限公司 | A kind of feed process of hyaluronic acid fermentation |
CN109468355A (en) * | 2018-10-16 | 2019-03-15 | 河北科技大学 | A method of improving fermenting and producing hyaluronan molecule amount |
CN109536550A (en) * | 2018-12-06 | 2019-03-29 | 上海景峰制药有限公司 | A kind of Sodium Hyaluronate and preparation method thereof |
-
2019
- 2019-12-27 CN CN201911379590.2A patent/CN111172222B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103320484A (en) * | 2013-06-28 | 2013-09-25 | 四川柯森油田化学有限公司 | Method for improving the fermentation yield of hyaluronic acid (HA) |
CN108192936A (en) * | 2018-03-19 | 2018-06-22 | 山东焦点生物科技股份有限公司 | A kind of feed process of hyaluronic acid fermentation |
CN109468355A (en) * | 2018-10-16 | 2019-03-15 | 河北科技大学 | A method of improving fermenting and producing hyaluronan molecule amount |
CN109536550A (en) * | 2018-12-06 | 2019-03-29 | 上海景峰制药有限公司 | A kind of Sodium Hyaluronate and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
吴祥坤等: "葡萄糖浓度及补料方式对透明质酸发酵的影响" * |
张容鹄等: "高分子量透明质酸产生菌选育及发酵条件优化" * |
郜娇娇等: "微生物发酵法生产高分子量透明质酸的研究进展" * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110452944A (en) * | 2019-09-21 | 2019-11-15 | 冯世红 | A method of hyaluronic acid is prepared using salt alcohol method |
CN114806938A (en) * | 2022-04-20 | 2022-07-29 | 齐鲁工业大学 | Streptococcus equi subsp zooepidemicus for producing hyaluronic acid in low-sugar environment and application thereof |
CN114806938B (en) * | 2022-04-20 | 2023-05-09 | 齐鲁工业大学 | Streptococcus equi subspecies zooepidemicus for producing hyaluronic acid in low-sugar environment and application thereof |
CN115960979A (en) * | 2022-12-30 | 2023-04-14 | 华熙生物科技股份有限公司 | Method for producing hyaluronic acid or salt thereof by fermentation |
Also Published As
Publication number | Publication date |
---|---|
CN111172222B (en) | 2024-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Freitas et al. | Engineering aspects of microbial exopolysaccharide production | |
CN111172222A (en) | Method for producing hyaluronic acid by fermentation and application thereof | |
Luo et al. | Microbial synthesis of poly-γ-glutamic acid: current progress, challenges, and future perspectives | |
Prajapati et al. | An insight into the emerging exopolysaccharide gellan gum as a novel polymer | |
Bajaj et al. | Gellan gum: fermentative production, downstream processing and applications | |
CN101935678B (en) | Method for producing hyaluronic acid fermentation liquor | |
ES2374512T3 (en) | PROCEDURE TO PRODUCE ELVADO HIALURONIC ACID MOLECULAR WEIGHT. | |
HUE029596T2 (en) | Preparation of sodium hyaluronate using a mutant of streptococcus zooepidemicus | |
da Silva et al. | Xanthan: biotechnological production and applications | |
CN109609408B (en) | Gamma-polyglutamic acid high-yield strain and method for preparing gamma-polyglutamic acid by using strain for liquid fermentation | |
CN104805143B (en) | A kind of method for preparing low molecule amount γ polyglutamic acids | |
CN106834387A (en) | A kind of method for preparing sodium hyaluronate | |
CN106367459A (en) | Method for preparing oligomeric hyaluronic acid with different molecular weights | |
JP5969390B2 (en) | Fucose-containing bacterial biopolymer | |
CN113493776B (en) | Method for continuously preparing enzyme-digested ultralow-molecular-weight hyaluronic acid or salt thereof | |
CN108624638B (en) | Method for producing glucosamine by fermentation | |
CN101294179A (en) | Method for preparing small-molecular weight hyaluronic acid by adding hyaluronate lyase in course of fermentation | |
JP2002176996A (en) | Production of exopolysaccharide unattached to surface of bacterial cell | |
CN113208059A (en) | Method for manufacturing edible pectin chitosan collagen 3D scaffold for cell culture meat | |
Moraes et al. | The existing studies on biosynthesis of poly (γ-glutamic acid) by fermentation. | |
Lai et al. | Medium formulation and impeller design on the biosynthesis of high molecular weight hyaluronic acid by Streptococcus zooepidemicus ATCC 39920 | |
KR101087969B1 (en) | Method of hyaluronic acid production through fermentation process from microorganism | |
CN108486032B (en) | Production method for acclimatizing hypertonic-resistant bacteria and improving hyaluronic acid yield | |
Saharkhiz et al. | Optimization Feed Composition on Hyaluronic Acid Production of in-Batch and Fed-Batch Cultures of Streptococcus zooepidemicus | |
CN106893749B (en) | Method for improving hyaluronic acid yield by externally adding metabolite in fermentation process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |